At the heart of GREG lies Work Package 9 (WP9) – Project Management and Coordination, led by SYNAPSE. This work package serves as the backbone of the GREG consortium, ensuring seamless collaboration, efficient resource allocation, and the successful delivery of the project’s objectives.
WP9 provides the operational, administrative, and strategic oversight needed to keep GREG running efficiently, on schedule, and within budget. Managing a large-scale European initiative means bringing together 29 diverse partners across academia, industry, regulatory bodies, and patient organizations. WP9 ensures everyone works toward the same shared goals.
The key responsibilities of WP9 include:
- Scientific and Technical Coordination: WP9 provides strategic direction to all scientific and technical activities within GREG. This involves monitoring WP progress to ensure alignment, facilitating communication across the WP leaders, stakeholders, and advisory boards; and adjusting project activities to address emerging challenges or opportunities.
- Day-to-Day Management: Efficient day-to-day operations are critical to GREG’s success. WP9 handles work plan monitoring, financial management, conflict resolution, and coordinates meetings.
- Reporting, Administration, and Legal Management: WP9 ensures compliance with all administrative and legal requirements, including periodic reporting and contractual obligations.
- Project Governance and Internal Communication: To maintain transparency and efficiency, WP9 establishes a governance structure that includes the General Assembly (GA), the Executive and Steering Committees, Work Packages, and Advisory Boards. WP9 also implements collaboration tools such as digital repositories, shared calendars, and mailing lists to streamline communication and document sharing.
- Quality Control and Risk Management: Ensuring the highest standards of quality is a priority for WP9. This involves ensuring strict quality control procedures, continuous risk assessment, and ethical oversight (Ethics Advisory Board).
The success of GREG relies on the cohesion and efficiency of its consortium. WP9 plays a pivotal role in:
- Maintaining cross-team alignment by coordinating the efforts of all WPs, ensuring that the project’s objectives are achieved in a cohesive and timely manner.
- Keeping the consortium management structure up to date and stable by preparing internal documentation that allow for the successful monitoring of the project progress. Strengthening the multi-stakeholder collaboration central to GREG’s mission by facilitating communication and promoting active engagement among stakeholders.
WP9 is led by SYNAPSE , but has key contributions from Erasmus MC, Novo Nordisk, the University of Oxford, and Sanofi.
“GREG comprises a diverse consortium of experts, organizations and stakeholders working towards a common goal. The core value of WP9 lies in providing stability, coordination and support needed for this collaboration to thrive. Our role is not only to keep the project on track but also create an environment that enables innovation and facilitates knowledge exchange across the consortium.” – Sharon Geerlings, WP9 leader from Synapse.
As GREG progresses, WP9 will continue to adapt and refine its approaches to meet the evolving needs of the project.
With a 5-year timeline and a total budget of €26.2 million, the stakes are high, but the team is well-equipped to navigate the challenges ahead!
